Profile
Keith E.
Anderson worked as a Senior Director-Pharmaceutical Development at Ligand Pharmaceuticals, Inc. from 2000 to 2007.
He then worked as the Chief Operating & Scientific Officer at Ocera Therapeutics, Inc. from 2012 to 2013.
Later, he worked as the Senior Vice President-Technical Operations at Sierra Oncology, Inc. from 2015 to 2022.
He also worked as the Vice President-Manufacturing at Seragon Pharmaceuticals, Inc. Dr. Anderson earned a doctorate degree from the University of Alberta.
Former positions of Keith E. Anderson
| Companies | Position | End |
|---|---|---|
| SIERRA ONCOLOGY, INC. | Corporate Officer/Principal | 2022-06-30 |
Ocera Therapeutics, Inc. /Old/
 Ocera Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocera Therapeutics, Inc. is a San Diego based, privately held biopharmaceutical company founded in January 2005 by Dr. Eckard Weber and Dr. Laurent Fischer. Ocera focuses on the development of novel therapeutics in the areas of liver and gastrointestinal diseases. | Chief Operating Officer | 2013-07-15 |
| LIGAND PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 2006-12-31 |
Seragon Pharmaceuticals, Inc.
 Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Training of Keith E. Anderson
| University of Alberta | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| Private companies | 3 |
|---|---|
Ocera Therapeutics, Inc. /Old/
Ocera Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocera Therapeutics, Inc. is a San Diego based, privately held biopharmaceutical company founded in January 2005 by Dr. Eckard Weber and Dr. Laurent Fischer. Ocera focuses on the development of novel therapeutics in the areas of liver and gastrointestinal diseases. | Health Technology |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Sierra Oncology, Inc. was a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focused on advanced targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded in May 2003 and is headquartered in San Mateo, CA. | Health Technology |
Seragon Pharmaceuticals, Inc.
Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Keith E. Anderson
